Literature DB >> 9311793

Expression and self-assembly of empty virus-like particles of hepatitis E virus.

T C Li1, Y Yamakawa, K Suzuki, M Tatsumi, M A Razak, T Uchida, N Takeda, T Miyamura.   

Abstract

Hepatitis E virus (HEV) is a pathogenic agent that causes fecally-orally transmitted acute hepatitis. The genome, a single-stranded positive-sense RNA, encodes three forward open reading frames (ORFs), in which an approximately 2-kb structural protein is located in the 3' end. To produce HEV-like particles the structural protein, with its N terminus truncated (amino acid residues 112 to 660 of ORF2), was expressed in insect Tn5 cells by a recombinant baculovirus. In addition to the primary translation product with a molecular mass of 58 kDa, a large amount of a further-processed molecule with a molecular mass of 50 kDa was generated and efficiently released into the culture medium. Electron microscopic observation of the culture medium revealed that the 50-kDa protein self-assembled to form empty virus-like particles (VLPs). The buoyant density of the VLPs in CsCl was 1.285 g/cm3 and their diameter was 23.7 nm, a little smaller than the 27 nm of native HEV particles secreted into the bile or stools of experimentally infected monkeys. The yield of the VLPs was 1 mg per 10(7) cells as a purified form. The particles possess antigenicity similar to that of authentic HEV particles and, consequently, they appear to be a good antigen for the sensitive detection of HEV-specific immunoglobulin G (IgG) and IgM antibodies. Furthermore, the VLP may be the most promising candidate yet for an HEV vaccine, owing to its potent immunogenicity.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9311793      PMCID: PMC192060          DOI: 10.1128/JVI.71.10.7207-7213.1997

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  31 in total

1.  Expression of gag precursor protein and secretion of virus-like gag particles of HIV-2 from recombinant baculovirus-infected insect cells.

Authors:  L Luo; Y Li; C Y Kang
Journal:  Virology       Date:  1990-12       Impact factor: 3.616

2.  Serial transmission of a putative causative virus of enterically transmitted non-A, non-B hepatitis to Macaca fascicularis and Macaca mulatta.

Authors:  T Uchida; K M Win; K Suzuki; K Komatsu; F Iida; T Shikata; T Rikihisa; K Mizuno; S Soe; H Myint
Journal:  Jpn J Exp Med       Date:  1990-02

3.  Virus of enterically transmitted non-A, non-B hepatitis.

Authors:  D W Bradley; M S Balayan
Journal:  Lancet       Date:  1988-04-09       Impact factor: 79.321

4.  Purification of a baculovirus-expressed hepatitis E virus structural protein and utility in an enzyme-linked immunosorbent assay.

Authors:  J He; W M Ching; P Yarbough; H Wang; M Carl
Journal:  J Clin Microbiol       Date:  1995-12       Impact factor: 5.948

5.  Enterically transmitted non-A, non-B hepatitis: serial passage of disease in cynomolgus macaques and tamarins and recovery of disease-associated 27- to 34-nm viruslike particles.

Authors:  D W Bradley; K Krawczynski; E H Cook; K A McCaustland; C D Humphrey; J E Spelbring; H Myint; J E Maynard
Journal:  Proc Natl Acad Sci U S A       Date:  1987-09       Impact factor: 11.205

6.  Assembly of empty capsids by using baculovirus recombinants expressing human parvovirus B19 structural proteins.

Authors:  C S Brown; J W Van Lent; J M Vlak; W J Spaan
Journal:  J Virol       Date:  1991-05       Impact factor: 5.103

7.  Expression of rotavirus VP2 produces empty corelike particles.

Authors:  M Labbé; A Charpilienne; S E Crawford; M K Estes; J Cohen
Journal:  J Virol       Date:  1991-06       Impact factor: 5.103

8.  Aetiological association of a virus-like particle with enterically transmitted non-A, non-B hepatitis.

Authors:  V A Arankalle; J Ticehurst; M A Sreenivasan; A Z Kapikian; H Popper; K M Pavri; R H Purcell
Journal:  Lancet       Date:  1988-03-12       Impact factor: 79.321

9.  Evidence for a virus in non-A, non-B hepatitis transmitted via the fecal-oral route.

Authors:  M S Balayan; A G Andjaparidze; S S Savinskaya; E S Ketiladze; D M Braginsky; A P Savinov; V F Poleschuk
Journal:  Intervirology       Date:  1983       Impact factor: 1.763

10.  Study of an epidemic of non-A, non-B hepatitis. Possibility of another human hepatitis virus distinct from post-transfusion non-A, non-B type.

Authors:  M S Khuroo
Journal:  Am J Med       Date:  1980-06       Impact factor: 4.965

View more
  95 in total

1.  Immunogenicity of HGV NS5 protein expressed from Sf9 insect cells.

Authors:  H Ren; F L Zhu; S Y Zhu; Y Song; Z T Qi
Journal:  World J Gastroenterol       Date:  2001-02       Impact factor: 5.742

2.  Identification of immunodominant and conformational epitopes in the capsid protein of hepatitis E virus by using monoclonal antibodies.

Authors:  M A Riddell; F Li; D A Anderson
Journal:  J Virol       Date:  2000-09       Impact factor: 5.103

3.  Poly(A)- and primer-independent RNA polymerase of Norovirus.

Authors:  Shuetsu Fukushi; Shigeyuki Kojima; Reiko Takai; Fuminori B Hoshino; Tomoichiro Oka; Naokazu Takeda; Kazuhiko Katayama; Tsutomu Kageyama
Journal:  J Virol       Date:  2004-04       Impact factor: 5.103

4.  The hepatitis E virus open reading frame 3 protein activates ERK through binding and inhibition of the MAPK phosphatase.

Authors:  Anindita Kar-Roy; Hasan Korkaya; Ruchi Oberoi; Sunil Kumar Lal; Shahid Jameel
Journal:  J Biol Chem       Date:  2004-04-19       Impact factor: 5.157

5.  Structure of hepatitis E virion-sized particle reveals an RNA-dependent viral assembly pathway.

Authors:  Li Xing; Tian-Cheng Li; Naoyuki Mayazaki; Martha N Simon; Joseph S Wall; Mary Moore; Che-Yen Wang; Naokazu Takeda; Takaji Wakita; Tatsuo Miyamura; R Holland Cheng
Journal:  J Biol Chem       Date:  2010-08-18       Impact factor: 5.157

Review 6.  Lessons learned from successful human vaccines: Delineating key epitopes by dissecting the capsid proteins.

Authors:  Xiao Zhang; Lu Xin; Shaowei Li; Mujin Fang; Jun Zhang; Ningshao Xia; Qinjian Zhao
Journal:  Hum Vaccin Immunother       Date:  2015       Impact factor: 3.452

7.  A bicistronic subgenomic mRNA encodes both the ORF2 and ORF3 proteins of hepatitis E virus.

Authors:  Judith Graff; Udana Torian; Hanh Nguyen; Suzanne U Emerson
Journal:  J Virol       Date:  2006-06       Impact factor: 5.103

8.  Latent infection of a new alphanodavirus in an insect cell line.

Authors:  Tian-Cheng Li; Paul D Scotti; Tatsuo Miyamura; Naokazu Takeda
Journal:  J Virol       Date:  2007-08-08       Impact factor: 5.103

Review 9.  Hepatitis E: an overview and recent advances in vaccine research.

Authors:  Ling Wang; Hui Zhuang
Journal:  World J Gastroenterol       Date:  2004-08-01       Impact factor: 5.742

10.  Polyphyletic strains of hepatitis E virus are responsible for sporadic cases of acute hepatitis in Japan.

Authors:  Hitoshi Mizuo; Kazuyuki Suzuki; Yasuhiro Takikawa; Yoshiki Sugai; Hajime Tokita; Yoshihiro Akahane; Keiichi Itoh; Yuhko Gotanda; Masaharu Takahashi; Tsutomu Nishizawa; Hiroaki Okamoto
Journal:  J Clin Microbiol       Date:  2002-09       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.